Investigator ratings of ADHD symptoms during a randomized, placebo-controlled trial of atomoxetine

A comparison of parents and teachers as informants

Bradley N. Bohnstedt, William Kronenberger, David Dunn, Ann L. Giauque, Elisabeth A. Wood, Mary E. Rembusch, Deborah Lafata

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

This study compared investigator ratings of ADHD symptoms based on interviews with parents and teachers during a double-blind, placebo-controlled study of atomoxetine. Investigators completed the ADHD Rating Scale: Investigator (ADHDRS-I) based on separate semistructured interviews with the primary caretaker and teacher of the participant. Interviews were conducted at Visits 2 to 7 during a double-blind treatment protocol comparing atomoxetine (N = 10) and placebo (N = 6). Both parent- and teacher-based ratings were sensitive to change in ADHD symptoms with atomoxetine treatment. Parent-based assessment differentiated significantly between treatment with atomoxetine and placebo, whereas teacher-based assessment was less sensitive to change. Parents and teachers showed good agreement on change in ADHDRS-I scores. Investigator ratings based on parent- and teacher-report were sensitive to change in symptoms of ADHD during treatment with atomoxetine. Despite good agreement between parent- and teacher-based ratings of symptom change, parent-based ADHD symptom ratings are more sensitive to symptom change.

Original languageEnglish
Pages (from-to)153-159
Number of pages7
JournalJournal of Attention Disorders
Volume8
Issue number4
DOIs
StatePublished - May 2005

Fingerprint

Randomized Controlled Trials
Placebos
Research Personnel
Interviews
Clinical Protocols
Therapeutics
Atomoxetine Hydrochloride

Keywords

  • ADHD
  • Assessment
  • Atomoxetine
  • Attention
  • Hyperactivity

ASJC Scopus subject areas

  • Psychology(all)

Cite this

Investigator ratings of ADHD symptoms during a randomized, placebo-controlled trial of atomoxetine : A comparison of parents and teachers as informants. / Bohnstedt, Bradley N.; Kronenberger, William; Dunn, David; Giauque, Ann L.; Wood, Elisabeth A.; Rembusch, Mary E.; Lafata, Deborah.

In: Journal of Attention Disorders, Vol. 8, No. 4, 05.2005, p. 153-159.

Research output: Contribution to journalArticle

@article{bd9be679fd8a4cdcb0d9fc61a112b03a,
title = "Investigator ratings of ADHD symptoms during a randomized, placebo-controlled trial of atomoxetine: A comparison of parents and teachers as informants",
abstract = "This study compared investigator ratings of ADHD symptoms based on interviews with parents and teachers during a double-blind, placebo-controlled study of atomoxetine. Investigators completed the ADHD Rating Scale: Investigator (ADHDRS-I) based on separate semistructured interviews with the primary caretaker and teacher of the participant. Interviews were conducted at Visits 2 to 7 during a double-blind treatment protocol comparing atomoxetine (N = 10) and placebo (N = 6). Both parent- and teacher-based ratings were sensitive to change in ADHD symptoms with atomoxetine treatment. Parent-based assessment differentiated significantly between treatment with atomoxetine and placebo, whereas teacher-based assessment was less sensitive to change. Parents and teachers showed good agreement on change in ADHDRS-I scores. Investigator ratings based on parent- and teacher-report were sensitive to change in symptoms of ADHD during treatment with atomoxetine. Despite good agreement between parent- and teacher-based ratings of symptom change, parent-based ADHD symptom ratings are more sensitive to symptom change.",
keywords = "ADHD, Assessment, Atomoxetine, Attention, Hyperactivity",
author = "Bohnstedt, {Bradley N.} and William Kronenberger and David Dunn and Giauque, {Ann L.} and Wood, {Elisabeth A.} and Rembusch, {Mary E.} and Deborah Lafata",
year = "2005",
month = "5",
doi = "10.1177/1087054705278797",
language = "English",
volume = "8",
pages = "153--159",
journal = "Journal of Attention Disorders",
issn = "1087-0547",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Investigator ratings of ADHD symptoms during a randomized, placebo-controlled trial of atomoxetine

T2 - A comparison of parents and teachers as informants

AU - Bohnstedt, Bradley N.

AU - Kronenberger, William

AU - Dunn, David

AU - Giauque, Ann L.

AU - Wood, Elisabeth A.

AU - Rembusch, Mary E.

AU - Lafata, Deborah

PY - 2005/5

Y1 - 2005/5

N2 - This study compared investigator ratings of ADHD symptoms based on interviews with parents and teachers during a double-blind, placebo-controlled study of atomoxetine. Investigators completed the ADHD Rating Scale: Investigator (ADHDRS-I) based on separate semistructured interviews with the primary caretaker and teacher of the participant. Interviews were conducted at Visits 2 to 7 during a double-blind treatment protocol comparing atomoxetine (N = 10) and placebo (N = 6). Both parent- and teacher-based ratings were sensitive to change in ADHD symptoms with atomoxetine treatment. Parent-based assessment differentiated significantly between treatment with atomoxetine and placebo, whereas teacher-based assessment was less sensitive to change. Parents and teachers showed good agreement on change in ADHDRS-I scores. Investigator ratings based on parent- and teacher-report were sensitive to change in symptoms of ADHD during treatment with atomoxetine. Despite good agreement between parent- and teacher-based ratings of symptom change, parent-based ADHD symptom ratings are more sensitive to symptom change.

AB - This study compared investigator ratings of ADHD symptoms based on interviews with parents and teachers during a double-blind, placebo-controlled study of atomoxetine. Investigators completed the ADHD Rating Scale: Investigator (ADHDRS-I) based on separate semistructured interviews with the primary caretaker and teacher of the participant. Interviews were conducted at Visits 2 to 7 during a double-blind treatment protocol comparing atomoxetine (N = 10) and placebo (N = 6). Both parent- and teacher-based ratings were sensitive to change in ADHD symptoms with atomoxetine treatment. Parent-based assessment differentiated significantly between treatment with atomoxetine and placebo, whereas teacher-based assessment was less sensitive to change. Parents and teachers showed good agreement on change in ADHDRS-I scores. Investigator ratings based on parent- and teacher-report were sensitive to change in symptoms of ADHD during treatment with atomoxetine. Despite good agreement between parent- and teacher-based ratings of symptom change, parent-based ADHD symptom ratings are more sensitive to symptom change.

KW - ADHD

KW - Assessment

KW - Atomoxetine

KW - Attention

KW - Hyperactivity

UR - http://www.scopus.com/inward/record.url?scp=24944514288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944514288&partnerID=8YFLogxK

U2 - 10.1177/1087054705278797

DO - 10.1177/1087054705278797

M3 - Article

VL - 8

SP - 153

EP - 159

JO - Journal of Attention Disorders

JF - Journal of Attention Disorders

SN - 1087-0547

IS - 4

ER -